Top compounds associated with response to DUPD1


Feature Type Standardized
Nominal ANOVA
mRNA CEP-701 GDSC1000 pan-cancer AAC 0.046 0.2
mRNA Lisitinib GDSC1000 pan-cancer AAC -0.047 0.2
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.045 0.2
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.047 0.2
mRNA temsirolimus CTRPv2 pan-cancer AAC 0.064 0.2
mRNA Mdivi-1 CTRPv2 pan-cancer AAC -0.049 0.2
mRNA MK-0752 CTRPv2 pan-cancer AAC -0.051 0.2
mRNA Obatoclax Mesylate GDSC1000 pan-cancer AAC 0.046 0.2
mRNA BRD-K94991378 CTRPv2 pan-cancer AAC -0.051 0.2
mRNA PD318088 CTRPv2 pan-cancer AAC -0.046 0.2
Download CSV